8-K: Beyond Air Stockholders Elect Directors, Approve Equity Plan

Beyond Air, Inc. announced the results of its 2026 Annual Meeting, where stockholders elected six directors, ratified its accounting firm, and approved an increase in shares for its equity incentive plan.

Summary

• The 2026 Annual Meeting of Stockholders was held on January 30, 2026.
• A total of 4,221,408 shares of common stock, representing 52.70% of the 8,009,488 shares outstanding and eligible to vote as of the December 3, 2025 record date, constituted a quorum.
• Six director nominees (Steven A. Lisi, Robert S. Goodman, Robert F. Carey, Dr. William Forbes, Yoori Lee, and Erick J. Lucera) were elected to serve until the next annual meeting.
• Stockholders ratified the appointment of WithumSmith+Brown, PC as the independent registered public accounting firm for the fiscal year ending March 31, 2026, with 4,086,430 votes For.
• The Eighth Amended and Restated 2013 Equity Incentive Plan was approved, increasing the number of shares reserved for issuance by 850,000, with 1,119,142 votes For.
• A proposal to approve the adjournment of the Annual Meeting, if necessary, was also approved, but was not required as all other proposals passed.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive procedural update, reflecting successful execution of routine corporate governance matters and approval of a key employee incentive plan, despite some dissent on the latter.

Positives

• All six director nominees were successfully elected, ensuring continuity in board leadership.
• The company's independent registered public accounting firm, WithumSmith+Brown, PC, was ratified with strong stockholder support, receiving over 96% of votes cast for the proposal.
• The approval of the equity incentive plan with an additional 850,000 shares provides the company with flexibility for future compensation and talent retention.

Negatives

• A notable portion of votes for the equity incentive plan were 'Against' (884,509 votes), indicating some stockholder dissent regarding the increase in shares reserved.
• Substantial 'Broker Non-Votes' were recorded for proposals requiring non-routine voting (director elections and equity plan), suggesting a lack of voting instructions from beneficial owners for these items.

Future Outlook

No explicit forward-looking statements or guidance were provided beyond the election of directors to serve until the next annual meeting and the approval of an equity incentive plan for future use in compensation and talent retention.

Industry Context

StockSavvy.ai notes that routine annual meeting results, such as director elections and auditor ratification, are standard corporate governance practices. The approval of an equity incentive plan is common for public companies to attract and retain talent, though the specific size of the increase can be a point of investor scrutiny depending on potential dilution concerns.

Comparison to Industry Standards

• The quorum of 52.70% of outstanding shares is typical for annual meetings, demonstrating sufficient shareholder engagement, comparable to attendance rates seen at other small-cap biotechnology firms.
• The ratification of the accounting firm with high approval (over 96% of votes cast) is standard and aligns with good corporate governance practices observed across the industry.
• The approval of an equity incentive plan is a common practice, comparable to similar plans at medical technology companies like Inogen (INGN) or Pulmonx (LUNG), which utilize such plans to incentivize employees in a competitive talent market.

Management Changes

Corporate Governance

Stakeholder Impact

• Shareholders: The approval of the equity incentive plan could lead to future share dilution, but also supports employee retention and motivation, which can benefit long-term shareholder value. The election of directors ensures continued board oversight.
• Employees: The increased share reserve in the equity incentive plan provides more opportunities for equity-based compensation, potentially boosting morale and retention.

Next Steps

• The newly elected directors will serve until the next annual meeting of stockholders or until their successors are elected and qualified.
• WithumSmith+Brown, PC will serve as the independent registered public accounting firm for the fiscal year ending March 31, 2026.
• The company can now issue up to an additional 850,000 shares under the Eighth Amended and Restated 2013 Equity Incentive Plan for compensation purposes.

Key Dates

Recommendation

The filing details routine annual meeting results, including director elections and auditor ratification, which are expected. The approval of the equity incentive plan is a common corporate action for talent retention. There are no new material financial disclosures or strategic shifts that would warrant a change in investment thesis based solely on this filing. Therefore, a 'hold' recommendation is appropriate as investors await more substantive operational or financial updates.

Keywords

Beyond Air, XAIR, Annual Meeting, Stockholder Vote, Director Election, Equity Incentive Plan, Corporate Governance, SEC Filing, 8-K, Nasdaq